Australia Crosses 9,000 For First Time
Asia-Pacific markets mostly rose, with Australian stocks among the top gainers, breaking ranks with key Wall Street peers that saw declines led by tech stocks.
In Japan, the Nikkei lost 278.38 points, or 0.7%, to 42,610.17. Losses were led by Daiichi Sankyo, Socionext and Lasertec Corp.
Yields on Japan’s 20-year government bonds rose to 2.645%, after hitting a 26-year high earlier in the session. Yields on the 10-year government bonds ticked up to a 17-year high of 1.61%.
In Hong Kong, the Hang Seng retreated 61.33 points, or 0.2%, to 25,104.61.
Australia’s S&P/ASX 200 benchmark rose 1.13% to end the day at a record high of 9,019.1. Gains were led by food company OMG Group, which surged 114.29%, printing and technology firm 333D, which jumped 55.56% and battery technology manufacturer Janus Electric Holdings, which rose 46.47%.
CHINA
In Shanghai, the CSI 300 regained 16.67 points, or 0.4%, to 4,288.07.
Shares of tech major Baidu fell as much as 5% after its total revenue of 32.71 billion yuan ($4.56 billion U.S.) during the three months ended June 30 fell 3.7% from the same period a year earlier. Analysts on average had estimated quarterly revenue at 32.76 billion yuan, according to data compiled by LSEG.
In other markets
In Singapore, the Straits Times index inched up 11.36 points, or 0.3%, to 4,230.90
In Korea, the Kospi recovered 11.65 points, or 0.4%, to 3,141.74.
In Taiwan, the Taiex index climbed 336.69 points, or 1.4%, to 23,962.13
In New Zealand, the NZX 50 popped 122.77 points, or 0.9%, to 13,194.07
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


